Contraline Secures $92.5M to Push Its Male Birth Control Candidates Forward
Contraline raised $92.5 million in new funding to advance its two male contraceptive candidates, including a once-daily topical gel and an implantable option.
Contraline raised $92.5 million in new funding to advance its two male contraceptive candidates, including a once-daily topical gel and an implantable option.
Luminai raised $38 million in Series B funding to scale its AI platform that automates healthcare administrative workflows. The company is working with Cleveland Clinic to expand the use of its system across high-volume processes, starting with referral management.
As providers continue to adopt AI in droves, payers are under pressure to modernize their own administrative operations. Alaffia Health says its clinically grounded AI platform can help health plans reduce waste and risk, a bet investors backed this week with a $55 million Series B funding round.
Apella raised an $80 million Series B funding round to expand its AI-powered platform designed to help hospitals optimize their operating rooms. The startup’s tool promises to boost surgical volume, reduce clinician burnout and improve patient access without adding new staff or facilities.
Function Health raised a $298 million Series B round, pushing its valuation into unicorn territory at $2.5 billion. The Austin-based startup offers subscribers access to more than 160 lab tests, as well as imaging.
EnsoData raised $20 million in Series B funds for its AI-powered sleep diagnostics. The company’s technology aims to help clinicians diagnose sleep disorders faster and more consistently.
SmarterDx — an AI startup that provides clinical review and quality audits for medical claims — closed a $50 million Series B funding round, bringing its total funding to date to $71 million.
HealthSnap closed a $25 million Series B funding round led by Sands Capital. The Miami-based company seeks to help providers better care for a rapidly aging and chronically ill population through its remote patient monitoring platform.
Turquoise Health closed a $30 million Series B round, which brings its total funding to date to $55 million. The San Diego-based startup, which has more than 160 customers, sells a platform that makes it easier for hospitals and payers to comply with price transparency regulations.
Armed with fresh capital, Nava Benefits hopes to take advantage of what it believes will be a disruption in the way smaller businesses approach health and wellness benefits, including the many digital tools now on the market.
Notable CEO Matthew De Silva said the company has been able to successfully replicate its automated system, allowing for the export of the company's technology and growth of its commercial use cases.
VirtualHealth founder and CEO Adam Sabloff said the company is not disclosing the dollar amount of the round at this time but noted that the financing round brings the total amount raised by VirtualHealth to more than $25 million.
GreatPoint Ventures led the Series B round for the San Francisco-based startup, and Tarsadia Investments, Crosslink Capital and Uncork Capital also participated.
Polaris Partners led the Series B round, and Ignition Partners, Osage University Partners, Mindset Ventures and UL Ventures also participated.
Black Granite Capital led the round, which the company, Jump Technologies, will use to expand its sales efforts and support product development.